search
Search
Vaccine Bonds launched to help save children's lives
Launch of "Vaccine Bonds" offer Japanese individuals investment opportunities while helping save the lives of children in the poorest countries Press Releases Tokyo, 1 June 2009 - HSBC Securities (Japan) Limited, in collaboration with the…
IFFIm rating action by FitchRatings follows UK downgrade
Fitch resumes stable outlook for IFFIm Washington DC, 22 April 2013 – FitchRatings has downgraded the International Finance Facility for Immunisation (IFFIm) by one notch from AAA to AA+ and is resuming a stable outlook. The short-term issuer…
Netherlands to join innovative funding programme for immunisation
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this…
IFFIm successfully prices its inaugural benchmark in Australian Dollars
The International Finance Facility for Immunisation Company (IFFIm) prices its inaugural Australian dollar benchmark, providing investors with a unique opportunity to help protect millions of children in the world's poorest countries against…
Mitsubishi UFJ Financial Group expected to offer 'Vaccine Bonds' to Japanese investors
Children in the world's poorest countries could benefit from a lifetime of protection from vaccine-preventable diseases thanks to the proposed sale next month of Vaccine Bonds to Japanese retail investors by Mitsubishi UFJ Financial Group 6 April…
IFFIm rating action by Moody’s follows UK downgrade
GAVI programmes continue to benefit from IFFIm funding Washington DC, 6 March 2013 – Moody’s Investors Service has downgraded the International Finance Facility for Immunisation (IFFIm) by one notch from Aaa to Aa1 and is maintaining a negative…
'Vaccine bonds' offer Japanese savers an ethical investment
"Vaccine bonds" will offer Japanese investors a fixed rate of return plus an opportunity to see their money used to help immunise children in the world's poorest countries Tokyo, 16 January 2009 - "Vaccine bonds" which are expected go on sale in…
Paris presentation introduces a new supranational bond issuer: The International Finance Facility for Immunisation
Proceeds Will be Used to Scale Up GAVI Alliance, Boost Vaccine Use and Improve Health Systems to Save Lives of Millions of Poorest Children Paris, 12 October 2006 - The International Finance Facility for Immunisation (IFFIm), the World Bank, as…
The UK's pioneering role in IFFIm: Building on a legacy and continuing to lead*
For decades, the United Kingdom has been a champion of global health—especially in its efforts to find innovative solutions to ensure life-saving vaccines reach those who need them most. At the heart of this commitment is the International Finance…
Mobilising resources to save lives
As countries face budget constraints, IFFIm will play a critical role in Gavi’s 2026-2030 funding.For over two decades, Gavi has been at the forefront of global health, championing equitable access to vaccines, improving immunisation rates, reducing…
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.